Recent Updates
Recently added Catalysts
CODX Positive Sentiment Score: 75/100

Co-Diagnostics, Inc. to Present and Host Booth at TRI-CON in San Diego, CA, March 6-8

Thursday, March 2, 2023 2 min read
Key Takeaway: Co-Diagnostics, Inc. will present and host a booth at the 30th Molecular and Precision Med TRI-CON from March 6-8, 2023, in San Diego, CA. As a Premier Sponsor, Co-Dx will deliver a Lunch Presentation focusing on its new Co-Dx PCR Home platform, which is undergoing clinical evaluations. The company is ramping up its marketing efforts in anticipation of regulatory approvals for commercialization. The event provides significant networking opportunities for the diagnostics and precision medicine community.

Market Sentiment Analysis

POSITIVE FACTORS

  • Co-Diagnostics will showcase its innovations at a prominent industry event.
  • The company is focused on commercializing the Co-Dx PCR Home platform.
  • Key additions to the marketing team signal a commitment to growth.

Full Press Release Details

SALT LAKE CITY, March 2, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the 30th Molecular and Precision Med TRI-CON ("TRI-CON"), held virtually and in person March 6-8, 2023, in San Diego, CA.
Co-Dx, which is also one of two Premier Sponsors of the event, will also be delivering the Lunch Presentation on Monday, March 6 at 11:55 am, focusing on its upcoming at-home/POCT Co-Dx PCR Home™ platform for which the initiation of clinical evaluations was recently announced. The Company has recently made key additions to its Marketing team in preparation for commercialization of the product, which the Company expects to commence upon receipt of the appropriate regulatory authorizations.
This year, TRI-CON celebrates nearly 3 decades of serving as the leading international meeting place for the diagnostics and precision medicine community, providing in-person networking opportunities for thousands of international thought leaders to discuss the latest research, technologies, innovation and business models across the biotech, healthtech, and medtech industries. To learn more about TRI-CON, including in-person and virtual registration details, please visit https://www.triconference.com/.
Attendees interested in learning more about the Company and its products, including its upcoming Co-Dx PCR Home platform (not currently for sale and subject to FDA review), are invited to visit Booth 100.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR Home™ platform and to locate genetic markers for use in applications other than infectious disease.
SOURCE Co-Diagnostics

21 %

more press release views with

Frequently Asked Questions

What is the Co-Dx PCR Home™ platform?

The Co-Dx PCR Home™ platform is a novel at-home molecular diagnostic test currently undergoing clinical evaluations.

When does the TRI-CON event take place?

The TRI-CON event is scheduled for March 6-8, 2023, in San Diego, CA.

What role does Co-Diagnostics play at TRI-CON?

Co-Diagnostics is a Premier Sponsor and will present a lunch session on March 6.

How can attendees learn about Co-Diagnostics products?

Attendees can visit Booth 100 at TRI-CON for more information about Co-Diagnostics.

What is the focus of TRI-CON?

TRI-CON emphasizes networking and discussions on the latest in diagnostics and precision medicine.

Tags: CODX Viatris Investor Conferences Healthcare Co-Diagnostics TRI-CON molecular diagnostics Co-Dx PCR Home San Diego
Last updated: Mar 2, 2023